HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Immunosuppression, Therapeutics and Pharmacology Abstracts

665 - Does the Development of Donor Specific Antibody after Heart Transplantation Depend on the Presence or Absence of Corticosteroids as Maintenance Therapy?

Presentation Number
665
Speakers
Session Name
POSTER SESSION 1 - POSTER SESSION: Heart Transplantation - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
655 - Assessment of Aortic Root Size in Donor Heart Predicts Short and Long Term Recipient Outcomes after Orthotopic Heart Transplantation

Next ePresentations
666 - 5-Year Outcome of Patients Weaned off Corticosteroids after Heart Transplantation: Is There a Downside?
668 - Incidence and Onset of Leukopenia in Adults the First Year after Orthotopic Heart Transplantation
670 - Mid-Term Effectiveness of Everolimus on Heart Transplant Recipients with Renal Dysfunction or Transplant Coronary Artery Atherosclerosis
671 - Post-Heart Transplant Outcomes of Sensitized Patients Who Have Undergone Desensitization Therapy
674 - Outcomes of Pre- Heart Transplantation Desensitization in Highly Sensitized Patients Bridged with Left Ventricular Assist Devices
675 - Does the Dose of Mycophenolate Mofetil Impact Outcome after Heart Transplantation?
677 - Pulmonary Hypertension Resolves Post Transplantation in Patients Treated with Milrinone or Dobutamine
686 - Outcomes of Heart Transplantation Bridging Strategies: Durable VAD vs IABP vs Medical Therapy
688 - Long Term Survival after Heart Transplantation is Not Affected by Axillary Intra Aortic Balloon Pump Support as a Bridge to Heart Transplantation
692 - Heart Transplantation Bridged by Extracorporeal Life Support in the Korean Adults: A 15 Year Single Center Experience